November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's ...
October 25, 2007 — Two carotid stenting trials examining outcomes in real-world patients demonstrated for the first time ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the ...
October 2, 2007 - Abbott said the FDA has granted waived status under the Clinical Laboratory Improvement Amendments of ...
September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...
September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel ...
August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and ...
July 19, 2007 – Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...